At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
First Liver Cancer Rx in Almost 10 Years
The US Food and Drug Administration (FDA) has approved the first medication to treat liver cancer in nearly 10 years.
How Ethnicity Affects Cancer Risk
Your ethnicity may be a factor in your cancer risk.
Smoking Might Be Even More Dangerous Than You Think
There are countless reasons to quit smoking. And new data may add 12 more reasons to the list.
Statins Could Help More Than Your Heart
High cholesterol and liver cancer may have a common enemy.
Cancer Survival Gains Not the Same for All Groups
Cancer patients are winning the battle against the disease like never before, but age and race may play a role in determining survival odds.
This Hep C Rx Combo May Be Quicker Cure
For people with hepatitis C, three isn't a crowd. These patients got well much faster with the addition of a third medication.
Cirrhosis: Usually Preventable but Common
Cirrhosis of the liver may usually be preventable, but it may be more common than previously thought. Fortunately, patients can take simple steps to keep their livers in tip-top shape.
Cancer Screening May Benefit Diabetes Patients
Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.
High Blood Glucose Levels Associated With Cancer
Having too much sugar in your blood, even if you are not diabetic, is considered unhealthy. And there may be an association between having high blood sugar levels and developing a serious health condition.
Liver Cancer Rx Failed Further Testing
Even when new medications show a lot of promise in the early stages of testing, they don't always prove to work so well in later stages of testing. For certain liver cancer patients, everolimus (Afinitor) may be less effective against tumors than previously thought.